Astarte Medical and Tiny Health Join Forces to Optimize Gut Health for Vulnerable Preterm Infants
YARDLEY, Pa. and AUSTIN, Texas, Sept. 21, 2023 /PRNewswire-PRWeb/ -- Astarte Medical, a leading pediatric clinical intelligence company, is forming a joint venture with Tiny Health, makers of gut microbiome tests for babies and expecting parents. The partners have agreed to develop a clinical-facing technology solution to support gut health for preterm and critically ill infants receiving care in the neonatal ICU.
- The partners have agreed to develop a clinical-facing technology solution to support gut health for preterm and critically ill infants receiving care in the neonatal ICU.
- "By partnering with Astarte Medical, we're extending our solution to support infants and families at their most vulnerable time.
- In a previous multi-center microbiome study, Astarte Medical identified six gut community types among nearly 300 preterm infants born under 34 weeks gestational age.
- Tiny Health will offer NICU parents the option to test their infants post-discharge to extend the understanding of the maturity patterns of infants born preterm.